Skip Navigation
National Institutes of Health: National Cancer Institute: Division of Cancer Control and Population Sciences
Grant Details

Grant Number: 5R21CA094715-03 Interpret this number
Primary Investigator: Christiani, David
Organization: Harvard University (Sch Of Public Hlth)
Project Title: Biomarkers of Carcinogen Exposure and Oxidative Injury
Fiscal Year: 2003
Back to top


Abstract

Cancer remains the second leading cause of death m the US preceded only by heart disease. The great majority of cancers are believed to be preventable because of known environmental factors that influence their incidence. Air pollution, predominantly composed of particulates including polycyclic aromatic hydrocarbons (PAH) and metals is known to contain significant levels of reactive oxygen species (ROS) which can lead to deleterious effects within a normal cell. Continued, repeated exposure to ROS (as seen in occupational exposures) leads to oxidative injury within a cell that can directly affect DNA, cell signaling and growth and the induction of mitosis and initiate the multi- step cascade of carcinogenesis. Previous epidemiologic studies have demonstrated increased cancer incidence among workers exposed to particulates and PAR The proposed investigation will use a repeated measures, short-term prospective approach to study exposure to particulates, PAH and metals and their relationship to oxidative injury biomarkers as intermediate factors in the development of cancer in a cohort of occupationally exposed individuals. This study will address important gaps in current knowledge of epidemiologic exposure assessment and will provide the opportunity to characterize both biologic markers of exposure (1-hydroxypyrene, mononuclear PAH- DNA adducts, urinary metals and urinary 7,8-dihydro-2'- deoxyguanosine;8-OH-dG), and biomarkers of early environmental carcinogen damage (PAH-DNA adducts, urinary 8-OH-dG). This study specifically addresses several of the key areas detailed in the RFA, including characterization and quantification of exposures and exposed populations via evaluation of the suitability of the use of several biomarkers simultaneously collected in surrogate tissue (blood DNA adducts, urinary metals, urinary 8-OH-dG and urinary 1- hydroxypyrene). A better understanding of these risks will lead to improved preventive strategies.

Back to top


Publications

pH increase observed in exhaled breath condensate from welding fume exposure.
Authors: Boyce P.D. , Kim J.Y. , Weissman D.N. , Hunt J. , Christiani D.C. .
Source: Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 2006 Apr; 48(4), p. 353-6.
PMID: 16607188
Related Citations

A urinary metabolite of phenanthrene as a biomarker of polycyclic aromatic hydrocarbon metabolic activation in workers exposed to residual oil fly ash.
Authors: Kim J.Y. , Hecht S.S. , Mukherjee S. , Carmella S.G. , Rodrigues E.G. , Christiani D.C. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005 Mar; 14(3), p. 687-92.
PMID: 15767350
Related Citations

Exposure to welding fumes is associated with acute systemic inflammatory responses.
Authors: Kim J.Y. , Chen J.C. , Boyce P.D. , Christiani D.C. .
Source: Occupational and environmental medicine, 2005 Mar; 62(3), p. 157-63.
PMID: 15723880
Related Citations

Urinary 8-hydroxy-2'-deoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to fine particulates.
Authors: Kim J.Y. , Mukherjee S. , Ngo L.C. , Christiani D.C. .
Source: Environmental health perspectives, 2004 May; 112(6), p. 666-71.
PMID: 15121508
Related Citations

Smoking status and occupational exposure affects oxidative DNA injury in boilermakers exposed to metal fume and residual oil fly ash.
Authors: Mukherjee S. , Palmer L.J. , Kim J.Y. , Aeschliman D.B. , Houk R.S. , Woodin M.A. , Christiani D.C. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004 Mar; 13(3), p. 454-60.
PMID: 15006923
Related Citations